LSA4 Protocol for the Treatment of Advanced Pediatric and Adolescent Non-Hodgkins Lymphoma

NCT00610883 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

17

Enrollment

OTHER

Sponsor class

Conditions

Non-Hodgkin's Lymphoma

Interventions

DRUG: LSA4, Cyclophosphamide, Methotrexate, Daunomycin, L-asparaginase, BCNU

Sponsor

Memorial Sloan Kettering Cancer Center